SSH -TALLAHASSEE INC. — History
CCN 102020 | 3-year financial timeline | COVID resilience: 52/100
🛡️ Public data only — no PHI permitted on this instance.
$25M
Latest Revenue (FY2022)
+4.1%
Revenue CAGR (3yr)
-3.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $23M | $25M | $25M | +0.0% | +4.1% |
| Operating Expenses | $23M | $26M | $26M | -1.9% | +5.1% |
| Operating Margin | -1.7% | -5.6% | -3.6% | +36.1% | +0.0% |
| Net Income | $-0M | $-1M | $-1M | +36.1% | +0.0% |
| Licensed Beds | 48 | 48 | 48 | +0.0% | +0.0% |
| Total Patient Days | 12,427 | 12,947 | 13,027 | +0.6% | +2.4% |
| Medicare Day % | 52% | 36% | 30% | -16.5% | -24.3% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 52/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +8.4% ($23M → $25M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+4.1%
This Hospital
+7.6%
State Avg
Latest Margin
-3.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $26M | -4.6% |
| FY2024 (proj) | $27M | -5.5% |
| FY2025 (proj) | $28M | -6.5% |